Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2000
06/29/2000WO2000037101A1 Method to produce inactivated w/o emulsion adjuvated vaccines
06/29/2000WO2000037097A1 Ribavirin-interferon alfa induction hcv combination therapy
06/29/2000WO2000037096A2 Treatment of hepatitis c virus infections with interleukin-10
06/29/2000WO2000037074A1 Mutilin 14-ester derivatives having antibacterial activity
06/29/2000WO2000037053A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
06/29/2000WO2000037051A1 Aerosol formulations for buccal and pulmonary application
06/29/2000WO2000037027A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
06/29/2000WO2000037022A2 Combination therapy for the treatment of sepsis
06/29/2000WO2000024437A8 Textured and porous silicone rubber
06/29/2000WO2000016757A8 Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants
06/29/2000WO2000012542A3 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
06/29/2000WO2000012506A3 Collections of compounds
06/29/2000WO2000012129A3 Salmonella typhi vaccine compositions
06/29/2000WO2000006737A3 Streptococcus pneumoniae proteins and nucleic acid molecules
06/29/2000WO2000001409A3 Porcine circovirus and parvovirus vaccine
06/29/2000DE19854310A1 Verwendung von Phosphonoameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen Using Phosphonoameisensäurederivaten for the therapeutic and prophylactic treatment of infections
06/29/2000CA2359586A1 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
06/29/2000CA2358492A1 Combination therapy for the treatment of sepsis
06/29/2000CA2357004A1 Expression of immunogenic hepatitis b surface antigens in transgenic plants
06/29/2000CA2356454A1 Compounds for intracellular delivery of therapeutic moieties to nerve cells
06/29/2000CA2356366A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
06/29/2000CA2356289A1 Organophosphorous compounds and use thereof
06/29/2000CA2356174A1 Kidney disease detection and treatment
06/29/2000CA2356162A1 Substituted tricyclics
06/29/2000CA2356159A1 Novel spla2 inhibitors
06/29/2000CA2356010A1 Treatment of hepatitis c virus infections with interleukin-10
06/29/2000CA2355876A1 Chlamydia trachomatis antigens
06/29/2000CA2355874A1 .alpha.v.beta.6 integrin inhibitors
06/29/2000CA2355840A1 Nephronin: a series of compounds for treatment of infectious diseases and cancer
06/29/2000CA2355836A1 Genetic suppressor elements against human immunodeficiency virus
06/29/2000CA2355694A1 Novel bicyclic compounds
06/29/2000CA2355680A1 Improved recombinant hepatitis b surface antigen
06/29/2000CA2355364A1 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
06/29/2000CA2355074A1 Lymphocytic membrane proteins
06/29/2000CA2354843A1 Outer surface proteins, their genes, and their use
06/29/2000CA2354536A1 Ribavirin-pegylated interferon alfa induction hcv combination therapy
06/29/2000CA2354135A1 Group b streptococcus proteins, and their use
06/29/2000CA2353848A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
06/29/2000CA2352309A1 Oral vaccine against diarrhea
06/29/2000CA2346960A1 Diagnostic and therapeutics for sepsis
06/28/2000EP1013764A1 Immunomodulators
06/28/2000EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same
06/28/2000EP1013757A2 Attenuated forms of bovine viral diarrhea virus
06/28/2000EP1013661A1 Novel bicyclonucleoside and oligonucleotide analogues
06/28/2000EP1013647A2 Process for the preparation of N-(amino-4,6-dihalogenopyrimidin)-formamides
06/28/2000EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
06/28/2000EP1013283A2 Pharmaceutical and foodstuff compositions containing transferrins and antibacteral agents for potentiating host defence activity and the treatment of infections
06/28/2000EP1013282A2 Pharmaceutical and foodstuff compositions containing transferrins and antibacteral agents for potentiating host defence activity and the treatment of infections
06/28/2000EP1013276A1 Aminoazacycloalkanes as CCR5 modulators
06/28/2000EP1013274A2 Composition comprising amoxycillin and clavulanic acid
06/28/2000EP1012331A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal
06/28/2000EP1012320A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/28/2000EP1012309A2 Chimeric polypeptides containing chemokine domains
06/28/2000EP1012305A1 Component of bromelain
06/28/2000EP1012304A1 Component of bromelain
06/28/2000EP1012295A1 Alphavirus rna replicon systems
06/28/2000EP1012293A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
06/28/2000EP1012285A1 Beta-defensins
06/28/2000EP1012267A2 An antisense oligonucleotide preparation method
06/28/2000EP1012266A1 Galectin 8, 9, 10 and 10sv
06/28/2000EP1012244A1 Rhabdoviruses with reengineered coats
06/28/2000EP1012242A1 Human sigma receptor
06/28/2000EP1012238A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl
06/28/2000EP1012187A2 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
06/28/2000EP1012181A1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
06/28/2000EP1012180A2 Hepatitis c inhibitor peptide analogues
06/28/2000EP1012158A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase
06/28/2000EP1012146A1 Hiv nuclear localization inhibitors
06/28/2000EP1012139A1 AZETIDINONE DERIVATIVES AS $g(b)-LACTAMASE INHIBITORS
06/28/2000EP1011721A1 Vaginal lactobacillus medicant
06/28/2000EP1011720A2 Mucosal cytotoxic t lymphocyte responses
06/28/2000EP1011718A1 Anti-viral treatment with pertussis toxin b oligomer
06/28/2000EP1011714A2 Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
06/28/2000EP1011701A1 Extracts of salvia species having antiviral activity
06/28/2000EP1011698A1 Chemical supplementation of bone
06/28/2000EP1011693A1 Use of locally delivered metal ions for treatment of periodontal disease
06/28/2000EP1011692A1 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY
06/28/2000EP1011689A1 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
06/28/2000EP1011664A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
06/28/2000EP1011657A1 Nitric oxide inhibits rhinovirus infection
06/28/2000EP1011652A1 Novel diarylsulfone non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus
06/28/2000EP1011637A1 Modulation of drug loading in multivesicular liposomes
06/28/2000EP1011636A1 New foam-forming pharmaceutical composition
06/28/2000EP1011567A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
06/28/2000EP0754057B1 Compositions and methods for vaccines comprising alpha-galactosyl epitopes
06/28/2000EP0732918B1 Benzalkonium fluoride injectable solution
06/28/2000EP0716601B1 Use of n,s-diacetylcysteine-ethylester (dacee) for the manufacture of a medicament for the treatment of viral diseases
06/28/2000EP0706394A4 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
06/28/2000CN1258301A Antiviral protease inhibitors
06/28/2000CN1258299A Multicyclic erythromycin derivs.
06/28/2000CN1258298A Process for preparation of metal salt of clavulanic acid
06/28/2000CN1258297A Process for producing beta-lactam derivs.
06/28/2000CN1258293A Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF 'alpha' levels
06/28/2000CN1258191A Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
06/28/2000CN1257872A Leptospiral vaccine antigen for preventing leptospirosis
06/28/2000CN1257711A Liquid medicine for treating beriberi
06/28/2000CN1053911C Closed-large ring lactone and closed-azalactones compounds and their preparation process
06/28/2000CN1053907C Process for manufacture of tricyclic compound
06/28/2000CN1053825C 'Wuling' hepatitis C powder
06/27/2000US6080851 Ribozymes with linked anchor sequences
1 ... 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 ... 1798